Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wege

Showing results (471-480 of 514) with videos related to

Pageof 52
Sort By:
Annals of Hepatology|August 15, 2024
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinomaLouisa Stern, Constantin Schmidt, Lorenz Kocheise, et al.
Liver Cancer|August 11, 2022
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter StudySabrina Welland, Catherine Leyh, Fabian Finkelmeier, et al.
The New Phytologist|April 21, 2019
Energy costs of salt tolerance in crop plantsRana Munns, David A Day, Wieland Fricke, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2026
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter surveyAndrea Gramegna, Carlo Magnoni, Chiara Premuda, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2019
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic SteatohepatitisJan Best, Lars P Bechmann, Jan-Peter Sowa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 20, 2022
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinomaMathew Vithayathil, Antonio D'Alessio, Claudia A M Fulgenzi, et al.
The New Phytologist|November 30, 2018
Energy costs of salinity tolerance in crop plantsStephen D Tyerman, Rana Munns, Wieland Fricke, et al.
JHEP Reports : Innovation in Hepatology|April 28, 2025
Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesisKornelius Schulze, Tim Daniel Rose, Lorenz Adlung, et al.
Hepatology International|April 3, 2023
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinomaMathew Vithayathil, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, et al.
Cancers|December 11, 2022
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus BevacizumabYue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, et al.
Pageof 52

Showing results (471-480 of 514) with videos related to

Sort By:
Pageof 52
Annals of Hepatology|August 15, 2024
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinomaLouisa Stern, Constantin Schmidt, Lorenz Kocheise, et al.
Liver Cancer|August 11, 2022
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter StudySabrina Welland, Catherine Leyh, Fabian Finkelmeier, et al.
The New Phytologist|April 21, 2019
Energy costs of salt tolerance in crop plantsRana Munns, David A Day, Wieland Fricke, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2026
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter surveyAndrea Gramegna, Carlo Magnoni, Chiara Premuda, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2019
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic SteatohepatitisJan Best, Lars P Bechmann, Jan-Peter Sowa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 20, 2022
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinomaMathew Vithayathil, Antonio D'Alessio, Claudia A M Fulgenzi, et al.
The New Phytologist|November 30, 2018
Energy costs of salinity tolerance in crop plantsStephen D Tyerman, Rana Munns, Wieland Fricke, et al.
JHEP Reports : Innovation in Hepatology|April 28, 2025
Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesisKornelius Schulze, Tim Daniel Rose, Lorenz Adlung, et al.
Hepatology International|April 3, 2023
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinomaMathew Vithayathil, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, et al.
Cancers|December 11, 2022
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus BevacizumabYue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, et al.
Pageof 52